Literature DB >> 10403778

Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene.

J M Pascussi1, Y Jounaidi, L Drocourt, J Domergue, C Balabaud, P Maurel, M J Vilarem.   

Abstract

Pregnane X Receptor (PXR) has been recently shown to regulate the inducible expression of CYP3A genes in response to xenobiotics and steroids. PXR forms a heterodimer with the retinoic acid receptor (RXR) and this complex binds to and transactivates an 18bp region containing two everted repeats TGA(A/C)CT separated by 6 nucleotides (ER6) and located at approximately -150 in the CYP3A4 promoter. In this work we have isolated and sequenced the proximal 5'-flanking region of CYP3A7 from two different human genomic libraries. In contrast to a previously reported sequence (Itoh et al., 1992), we did not observe any mutation in the 3'-half of the CYP3A7 ER6 element. Using electrophoretic mobility shift assays and cotransfection experiments we show that this element is able to bind the PXR:RXR complex and transactivates the expression of a down stream promoter in response to rifampicin, clotrimazole, and RU-486, three compounds known to specifically activate the human PXR. This is consistent with the fact that CYP3A7 mRNA is inducible in several primary cultures of human hepatocytes from different patients, as well as in two hepatocarcinoma cell lines HuH7 and HepG2, in response to these compounds. In contrast to a previous report (Blumberg et al., 1998), based on the sequence published by Itoh et al., we conclude that CYP3A7, like CYP3A4, is inducible in response to xenobiotics and presumably in a large proportion of the population. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403778     DOI: 10.1006/bbrc.1999.0745

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Discovery of Transcriptional Targets Regulated by Nuclear Receptors Using a Probabilistic Graphical Model.

Authors:  Mikyung Lee; Ruili Huang; Weida Tong
Journal:  Toxicol Sci       Date:  2015-12-07       Impact factor: 4.849

Review 2.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

Review 3.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.

Authors:  Edith J Mensah-Osman; Dafydd G Thomas; Michelle M Tabb; Jose M Larios; Dennis P Hughes; Thomas J Giordano; Michelle L Lizyness; James M Rae; Bruce Blumberg; Paul F Hollenberg; Laurence H Baker
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

Review 5.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

Review 6.  Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

Authors:  P Honkakoski; M Negishi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

7.  Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression.

Authors:  Dione Gardner-Stephen; Jean-Marie Heydel; Amit Goyal; Yuan Lu; Wen Xie; Tim Lindblom; Peter Mackenzie; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2004-03       Impact factor: 3.922

8.  Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.

Authors:  Caroline Raynal; Jean-Marc Pascussi; Géraldine Leguelinel; Cyril Breuker; Jovana Kantar; Benjamin Lallemant; Sylvain Poujol; Caroline Bonnans; Dominique Joubert; Frédéric Hollande; Serge Lumbroso; Jean-Paul Brouillet; Alexandre Evrard
Journal:  Mol Cancer       Date:  2010-03-02       Impact factor: 27.401

Review 9.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

10.  Shear stress activation of nuclear receptor PXR in endothelial detoxification.

Authors:  Xiaohong Wang; Xi Fang; Jing Zhou; Zhen Chen; Beilei Zhao; Lei Xiao; Ao Liu; Yi-Shuan J Li; John Y-J Shyy; Youfei Guan; Shu Chien; Nanping Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.